CA2707445A1 - Inhibiteurs tetrahydro-isoquinolino de ppat utilises en tant qu'agents antibacteriens - Google Patents

Inhibiteurs tetrahydro-isoquinolino de ppat utilises en tant qu'agents antibacteriens Download PDF

Info

Publication number
CA2707445A1
CA2707445A1 CA2707445A CA2707445A CA2707445A1 CA 2707445 A1 CA2707445 A1 CA 2707445A1 CA 2707445 A CA2707445 A CA 2707445A CA 2707445 A CA2707445 A CA 2707445A CA 2707445 A1 CA2707445 A1 CA 2707445A1
Authority
CA
Canada
Prior art keywords
independently
compound
alkyl
aryl
aralkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2707445A
Other languages
English (en)
Inventor
Roger Frechette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biota Scientific Management Pty Ltd
Original Assignee
Biota Scientific Management Pty Ltd
Roger Frechette
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scientific Management Pty Ltd, Roger Frechette filed Critical Biota Scientific Management Pty Ltd
Publication of CA2707445A1 publication Critical patent/CA2707445A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA2707445A 2007-11-30 2008-11-26 Inhibiteurs tetrahydro-isoquinolino de ppat utilises en tant qu'agents antibacteriens Abandoned CA2707445A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99152507P 2007-11-30 2007-11-30
US60/991,525 2007-11-30
PCT/US2008/084948 WO2009073545A2 (fr) 2007-11-30 2008-11-26 Inhibiteurs tétrahydro-isoquinolino de ppat utilisés en tant qu'agents antibactériens

Publications (1)

Publication Number Publication Date
CA2707445A1 true CA2707445A1 (fr) 2009-06-11

Family

ID=40718459

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2707445A Abandoned CA2707445A1 (fr) 2007-11-30 2008-11-26 Inhibiteurs tetrahydro-isoquinolino de ppat utilises en tant qu'agents antibacteriens

Country Status (6)

Country Link
EP (1) EP2225207A2 (fr)
JP (1) JP2011518109A (fr)
CN (1) CN102007101A (fr)
AU (1) AU2008334075A1 (fr)
CA (1) CA2707445A1 (fr)
WO (1) WO2009073545A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009073534A2 (fr) 2007-11-30 2009-06-11 Maxthera Inc. Inhibiteurs de ppat bicycliques utilisés en tant qu'agents antibactériens
FR2986002B1 (fr) 2012-01-24 2014-02-21 Servier Lab Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN102603755B (zh) * 2012-02-08 2015-09-09 中国人民解放军第二军医大学 一类具有协同氟康唑抗耐药真菌作用的化合物
FR3008977A1 (fr) 2013-07-23 2015-01-30 Servier Lab Nouveaux derives d'isoindoline ou d'isoquinoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3008975A1 (fr) 2013-07-23 2015-01-30 Servier Lab Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3008976A1 (fr) 2013-07-23 2015-01-30 Servier Lab "nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent"
ES2838573T3 (es) 2014-08-21 2021-07-02 Bristol Myers Squibb Co Derivados de benzamida ligados como inhibidores potentes de ROCK
BR112018002710B1 (pt) * 2015-08-12 2022-06-28 Syngenta Participations Ag Composto derivado heterobicíclico microbicida, composição compreendendo o mesmo e método de combate, prevenção ou controle de doenças fitopatogênicas
CN113461699B (zh) * 2021-04-14 2022-06-21 宁波大学 一种四环吡咯生物碱类化合物及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1165555B1 (fr) * 1999-03-11 2003-07-16 Neurogen Corporation Pyridines 2,4-disubstituees fusionnees avec un aryle: ligands du recepteur nk-3
US20050070570A1 (en) * 2003-06-18 2005-03-31 4Sc Ag Novel potassium channels modulators
EP1637529A1 (fr) * 2004-09-20 2006-03-22 4Sc Ag Nouveaux analogues de piperidin-4-yl-thiazole-carboxamide en tant qu'inhibiteurs de proliferation de lymphocytes T er leurs utilisations
EP1994017A2 (fr) * 2006-03-15 2008-11-26 4Sc Ag Nouveaux inhibiteurs hétérocycliques de nf/kb

Also Published As

Publication number Publication date
WO2009073545A3 (fr) 2009-09-11
CN102007101A (zh) 2011-04-06
WO2009073545A2 (fr) 2009-06-11
EP2225207A2 (fr) 2010-09-08
JP2011518109A (ja) 2011-06-23
AU2008334075A1 (en) 2009-06-11

Similar Documents

Publication Publication Date Title
CA2707445A1 (fr) Inhibiteurs tetrahydro-isoquinolino de ppat utilises en tant qu'agents antibacteriens
JP7111790B2 (ja) イミダゾロニルキノリンおよびａｔｍキナーゼ阻害剤としてのその使用
AU2006313590B2 (en) Use of pyrroloquinoline compounds to kill clinically latent microorganisms
JP5143000B2 (ja) 抗感染症薬としての８−メトキシ−９Ｈ−イソチアゾロ［５，４−ｂ］キノリン−３，４−ジオンおよび関連化合物
ES2602203T3 (es) Derivados de sulfóxido para el tratamiento de tumores
EP2609082B1 (fr) Imidazo[4,5-c]quinolines utilisés en tant qu'inhibiteurs d'adn-pk
WO2008056151A1 (fr) Formulations topiques
US8124616B2 (en) Bicyclic PPAT inhibitors as antibacterial agents
WO2003055890A1 (fr) Composes derives de thienopyrimidine utilises comme inhibiteurs de la prolylpeptidase, inducteurs d'apoptose et agents de traitement anticancereux
JP2012522807A (ja) 抗感染症薬としてのヒドロキシチエノキノロン類および関連化合物
JP6869176B2 (ja) Ｃｒｔｈ２アンタゴニストとしての化合物およびその使用
EP1628977B1 (fr) DERIVES DE TETRAHYDRO-b-CARBOLINE ANTIBIOTIQUES
EP2240493A2 (fr) Dérivés de tétrahydro-bêta-carboline antibiotiques
WO2014044645A1 (fr) Dérivés de macrolide, leur préparation et leur utilisation thérapeutique
WO2004064837A1 (fr) Antibacterien inhibiteur du fab i
CA2534957A1 (fr) Derives de cycloalkyltetrahydroquinoline antibiotique
WO2009073550A2 (fr) Tétrahydroquinolines substituées utilisées en tant qu'agents antibactériens
JP2024518447A (ja) ＰＫＣ－θモジュレーター
US20090170844A1 (en) Spiro Tetracyclic Compound
JP2008528551A (ja) インドロピリジン、ベンゾフラノピリジン及びベンゾチエノピリジン

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20121126